Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Mallinckrodt plc (MNK)

4.17   -0.95 (-18.55%) 02-24 16:00
Open: 4.93 Pre. Close: 5.12
High: 5.2265 Low: 2.52
Volume: 23,835,852 Market Cap: 353M
Mallinckrodt PLC is a drug manufacturing company that develops, manufactures, markets and distributes specialty pharmaceutical and biopharmaceutical products. It operates in two segments including branded pharmaceuticals and generic drugs.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 5.235 - 5.264 5.264 - 5.288
Low: 2.486 - 2.503 2.503 - 2.518
Close: 4.126 - 4.171 4.171 - 4.207

Technical analysis

as of: 2020-02-24 4:45:30 PM
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 5.76     One year: 7.50
Support: Support1: 2.52    Support2: 2.10
Resistance: Resistance1: 4.93    Resistance2: 6.42
Pivot: 4.95
Moving Average: MA(5): 4.81     MA(20): 4.91
MA(100): 3.65     MA(250): 8.47
MACD: MACD(12,26): 0.10     Signal(9): 0.21
Stochastic oscillator: %K(14,3): 61.11     %D(3): 56.51
RSI: RSI(14): 41.97
52-week: High: 25.54  Low: 1.43  Change(%): -82.4
Average Vol(K): 3-Month: 748038  10-Days: 893172

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
MNK has closed below the lower band by 7.3%. Although price has broken the lower band and a downside breakout is possible; the most likely direction for MNK is to continue within current trading range. Bollinger Bands are 1.2% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Mon, 24 Feb 2020 22:19:19 +0000
Mallinckrodt Considers Bankruptcy Over Opioid Lawsuits

Thu, 06 Feb 2020 17:58:54 +0000
4 Stocks Looking Higher

Fri, 31 Jan 2020 21:35:00 +0000
Biotech Bankruptcies Hit Recent High in 2019

Sun, 19 Jan 2020 14:00:00 +0000
3 Big Winners From the "Super Bowl of Healthcare"

Wed, 08 Jan 2020 18:03:01 +0000
Scandal-Ridden Teva Pharmaceutical Is Fishing for a Bottom

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  New York Stock Exchange
Sector:  Healthcare
Industry:  Drug Manufacturers - Specialty Generic
Shares Out. (M) 84.09
Shares Float (M) 76.09
% Held by Insiders 2.78
% Held by Institutions 102.91
Shares Short (K) 46160
Shares Short P. Month (K)

Stock Financials

EPS -42.507
Book Value (p.s.) 36.640
PEG Ratio -0.03
Profit Margin -111.44
Operating Margin 6.71
Return on Assets (ttm) 1.1
Return on Equity (ttm) -73.6
Qtrly Rev. Growth -7.0
Gross Profit (p.s.) 18.908
Sales Per Share
EBITDA (p.s.) 14.152
Qtrly Earnings Growth
Operating Cash Flow (M) 718.50
Levered Free Cash Flow (M) 1300.00

Stock Valuations

P/E -0.10
P/E Growth Ratio -0.19
P/BV 0.11
P/S 0.10
P/CF 0.49

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date 2012-12-11
Last Split Ratio 0.5
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.